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Abstract
Background: Genetic and epigenetic factors interacting with the environment over time are the main causes of complex
diseases such as autoimmune diseases (ADs). Among the environmental factors are organic solvents (OSs), which are
chemical compounds used routinely in commercial industries. Since controversy exists over whether ADs are caused by OSs,
a systematic review and meta-analysis were performed to assess the association between OSs and ADs.
Methods and Findings: The systematic search was done in the PubMed, SCOPUS, SciELO and LILACS databases up to
February 2012. Any type of study that used accepted classification criteria for ADs and had information about exposure to
OSs was selected. Out of a total of 103 articles retrieved, 33 were finally included in the meta-analysis. The final odds ratios
(ORs) and 95% confidence intervals (CIs) were obtained by the random effect model. A sensitivity analysis confirmed results
were not sensitive to restrictions on the data included. Publication bias was trivial. Exposure to OSs was associated to
systemic sclerosis, primary systemic vasculitis and multiple sclerosis individually and also to all the ADs evaluated and taken
together as a single trait (OR: 1.54; 95% CI: 1.25–1.92; p-value,0.001).
Conclusion: Exposure to OSs is a risk factor for developing ADs. As a corollary, individuals with non-modifiable risk factors
(i.e., familial autoimmunity or carrying genetic factors) should avoid any exposure to OSs in order to avoid increasing their
risk of ADs.
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Introduction
Autoimmune diseases (ADs) are initiated by the loss of immune
tolerance and mediated through T or B cell activation leading to
tissue damage. ADs share clinical signs and symptoms, physio-
pathological mechanisms, and genetic factors [1]. They are
complex diseases caused by the interaction between genetic,
epigenetic, and environmental factors over time [2,3].
Despite the difficulties in defining environmental risk factors
that lead to immunopathology, the number of candidates
proposed for specific ADs is continuously growing as new evidence
is reported for infectious agents, chemicals, physical factors,
adjuvants, and hormones [4–15]. A significant body of research
has pointed out that, for autoimmunity to occur, the genetic
background warrants to be combined with environmental injuries
and novel associations has been described as the case of the air
pollution [5,16]. However these environmental factors often
explain only a small number of cases, and, on their own, they
are not sufficient to cause the disease [5].
Solvents are liquids that dissolve a solid, liquid or gas. They can
be broadly classified into two categories: organic and inorganic.
Organic solvents (OSs) are compounds whose molecules contain
carbon. They may be broken down further into aliphatic-chain
compounds, such as n-hexane, and aromatic compounds with a 6-
carbon ring, such as benzene or xylene. OSs arose in the latter half
of the 19th century from the coal-tar industry. Common uses for
OSs are: dry cleaning (e.g., tetrachloroethylene), paint thinner
(e.g., toluene, turpentine), nail polish removers and glue solvents
(acetone, methyl acetate, ethyl acetate), spot removers (e.g.,
hexane, petrol ether), detergents (citrus turpenes), perfumes
(ethanol), nail polish and chemical synthesis [17]. In contrast,
the use of inorganic solvents (other than water) is typically limited
to research in chemistry and some technological processes.
The applications of OSs became more diversified in both
developed and developing countries. Research in this area began
in 1957 when the first patients developing a scleroderma-like
syndrome after exposure to vinyl chloride, epoxy resins, trichlo-
roethylene (TCE), perchloroethylene and other mixed solvents
were reported [18,19]. Nevertheless, few published studies have
analyzed the wide spectrum of ADs in subjects exposed to OSs.
Therefore, we aimed to analyze the evidence of an association
between the exposure to OSs and the development of AD through
a systematic literature review and a meta-analysis. In addition, a
comprehensive review concerning the mechanisms by which OSs
exposure induces immunological alterations is presented.
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Methods
Literature Search
The search was done using the following databases: PubMed,
SCOPUS, SciELO and LILACS and took into account articles
published up to February 2012. We followed the PRISMA
guidelines for meta-analysis of observational studies [20] in our
data extraction, analysis, and reporting (Text S1).
The most relevant terms regarding OSs exposure were
suggested by an expert chemical engineer specialist in industrial
hygiene. The following Medical Subject Heading (MeSH) terms
were used: ‘‘systemic vasculitis,’’ ‘‘vasculitis,’’ ‘‘rheumatoid arthri-
tis,’’ ‘‘lupus,’’ ‘‘multiple sclerosis,’’ ‘‘scleroderma,’’ ‘‘systemic
sclerosis,’’ ‘‘antiphospholipid syndrome,’’ ‘‘Sjo¨gren’s syndrome,’’
‘‘dermatomyositis,’’ ‘‘polymyositis,’’ ‘‘myasthenia gravis,’’ ‘‘Churg-
Strauss syndrome,’’ ‘‘giant cell arteritis,’’ ‘‘microscopic polyangii-
tis,’’ ‘‘cryoglobulinemia,’’ ‘‘polyarteritis nodosa,’’ ‘‘Wegener gran-
ulomatosis,’’ ‘‘inflammatory bowel diseases,’’ ‘‘anemia, perni-
cious,’’ ‘‘thyroiditis, autoimmune,’’ ‘‘celiac disease,’’ ‘‘juvenile
rheumatoid arthritis,’’ ‘‘vitiligo,’’ ‘‘primary biliary cirrhosis,’’
‘‘biliary cirrhosis,’’ ‘‘primary sclerosing cholangitis,’’ ‘‘autoimmune
hepatitis,’’ ‘‘transverse myelitis,’’ ‘‘relapsing polychondritis,’’ ‘‘Ad-
dison disease,’’ ‘‘glomerulonephritis,’’ ‘‘idiopathic thrombocytope-
nic purpura,’’ ‘‘psoriatic arthritis,’’ ‘‘spondylitis, ankylosing,’’
‘‘sarcoidosis,’’ ‘‘Raynaud’s disease,’’ ‘‘connective tissue disease,’’
and ‘‘autoimmune disease.’’ Each one of them was cross-
referenced with the following MeSH terms: ‘‘solvent,’’ ‘‘tetrachlo-
roethylene,’’ ‘‘trichloroethylene,’’ ‘‘trichloroethane,’’ ‘‘perchloreth-
ylene,’’ ‘‘toluene,’’ ‘‘vinyl chloride,’’ ‘‘acetone,’’ ‘‘ethylacetate,’’
‘‘turpentine,’’ ‘‘benzene,’’ ‘‘5-hydroxytryptophan,’’ ‘‘diethylpropi-
on,’’ ‘‘fenfluramine,’’ and ‘‘hair dye.’’ Furthermore, we used ‘text
words’ if there was no MeSH term such as in the cases of
‘‘hexane,’’ ‘‘white spirit,’’ ‘‘urea formaldehyde,’’ and ‘‘nail polish.’’
In addition, each MeSH term was translated into DeCS (Health
Sciences Descriptors), the tool that permits navigation between
records and sources of information through controlled concepts
and organized in Portuguese, Spanish and English, in order to
search the SciElo and LILACS databases. No limits regarding
language, period of publication, or publication type were taken
into account. Those references from the articles that seemed to be
relevant for our review were hand-searched. Authors of publica-
tions to which full text access was unavailable were contacted via
e-mail.
In addition, a systematic search was done in the PubMed
database up to February 2012 looking for the molecular
mechanisms by which OSs may alter immune responses and
induce the developing of ADs. The search was restricted to: (1)
studies in humans and mice, (2) restricted by title and (3) English
language, (4) articles published in the last 20 years, (5) studies in
ADs (6) studies including the term autoimmunity, (7) studies
including the term ‘‘immune system’’. All of the search strategies
included MeSH terms: ‘‘Tetrachloroethylene’’, ‘‘Trichloroethy-
lene’’, ‘‘Trichloroethanes’’, ‘‘Perchlorethylene’’, ‘‘Toluene’’, ‘‘Vi-
nyl Chloride’’, ‘‘Acetone’’, ‘‘Ethylacetate’’, ‘‘Turpentine’’, ‘‘
Benzene ’’, ‘‘5-Hydroxytryptophan’’, ‘‘Diethylpropion’’, ‘‘Fenflur-
amine’’, ‘‘Hair Dyes’’, ‘‘Hexane’’, ‘‘Immune System’’, and
‘‘autoimmunity’’. Furthermore, we used key words if there was
no MeSH term such as in the cases of ‘‘white spirit’’, ‘‘urea
formaldehyde’’, ‘‘nail polish and ‘‘autoimmune diseases’’. The
exclusion criteria were the following: 1) Articles related to immune
alterations due to allergic responses in solvent exposure, 2) articles
related to cytotoxic and genotoxic effects of solvent in cancer
progression, 3) articles in a language other than English, 4)
reviews, 5) comments and case reports that did not report any
biological implication related to solvent exposure.
Study Selection, Data Extraction, and Quality Assessment
Inclusion criteria for the systematic review were the following:
any types of study that used accepted classification criteria for ADs
and had information about exposure to OSs explicitly listed as a
category.
Articles were excluded from the analysis if they included the
same data that were published in another study.
Abstracts and full text articles were reviewed in the search for
eligible studies. Two reviewers did the search independently while
applying the same selection criteria. The two resulting databases
were compared and disagreements resolved by consensus. For
articles in languages other than English or Spanish, translations of
abstracts or full text articles were reviewed to determine eligibility.
Each eligible study was classified as: review, case report, case
series, cohort, or case-control. Inclusion criteria for the meta-
analysis were applied to publications that provided epidemiologic
data on risk factors [relative risks (RR) and odds ratios (OR) with
confidence intervals (CI)] or that provided information that let us
calculate these data. For cohort studies, the requirements were the
number of subjects exposed, the number unexposed, and the
number of subjects who developed the disease in each of the two
cases. For case-control studies, the requirements were the number
of subjects with AD that were exposed and not exposed, and the
number of controls that were exposed and not exposed. In those
instances where the study had not reported the number of subjects
in each group, either the RR or the OR with the CI, at least, must
have been reported in order for them to be included in the meta-
analysis calculations.
Studies were excluded from the meta-analysis if the groups were
not clearly defined, e.g. case- controls studies with likely AD
diagnosis in control subjects or exposed cohorts with low specificity
for OS.
For each eligible study, the type of exposure and exposure
assessment was analyzed regarding the source of information
(census, database, interview, mailed questionnaires, etc.) and
classified as follows: ‘‘qualitative’’ if it was stated by the subject or
interviewer on questionnaires measured by the quality of exposure
rather than its quantity, ‘‘quantitative’’ if it was related to a
number or quantity, and ‘‘semi-quantitative’’ if it was expressed as
a quantity susceptible of measurement but was not related to a
number. Quantitative assessment was sub-classified in ‘‘indirect
quantitative’’ if it was defined by an estimate from a register of
specific jobs at risk or calculated using a job-exposure matrix
formula, and ‘‘direct quantitative’’ if the OS was directly measured
in the environment or as a biomarker in the subject. Furthermore
it was extracted the information that described the condition of
exposure (e.g occupation, living characteristics.)
The quality and strength of scientific evidence was evaluated
supporting an etiologic relationship between ADs and the
proposed risk factor. In this investigation, a quantitative scoring
system based on the Bradford Hill criteria was used [21]. The
quantitative Bradford Hill score (qBHs) is divided into categorical
ratings of the overall strength of causal association as follows: 0 to
6 points was considered poor or no causal association; 7 to
14 points was considered moderate or inconclusive causal
association, and 15 to 21 points was considered a strong causal
association. No study was excluded from the review based on this
assessment.
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Meta-analysis
Data were analyzed using the Comprehensive Meta-Analysis
version 2 program (Biostat, Englewood, NJ, 2004). Calculations
were carried out for the whole group of articles depending on the
binary data available for any AD: number of subjects and risk data
(OR and RR with the corresponding 95% CI). Effect size was
calculated based on studies that only showed the OR and
respective 95% CI and the raw data from case-control and cohort
studies. A second effect size was calculated independently with
studies that only showed the RR and the respective 95% CI and
the raw data from cohort studies. Different study designs were
used to compute the same effect size since the effect size had the
same meaning in all studies and were comparable in relevant
aspects. Thus, this study was able to transform all values to log
values (log odds ratio and standard error), which were used in the
pooled analysis. This approach prevented the omission of studies
that used an alternative measure.
A sensitivity analysis was done in which the meta-analysis results
of the studies as a whole was compared to the same meta-analysis
with one study excluded in each round to determine how robust
the findings were. It was also done to evaluate the impact of
decisions that lead to different data being used in the analysis and
whether the conclusions reached might differ substantially if a
single study or a number of studies were omitted.
Additional meta-analyses were done for studies with complex
data structure and non-cumulative results if the information for
the different effects was not totally independent. Thus, articles
showing multiple independent subgroups within a study were
considered in these analyses (i.e. different definitions of the disease,
gender differences, toxic exposure or more than one comparison
group within a study). To compare effects across subgroups we
typically use subgroup as the unit of analysis in an independent
meta-analysis.
Supplementary analyses were done for the association between
each specific AD and OSs exposure. Additional analyses were also
done grouping the data according to the exposure assessment
category.
ORs were grouped by weighing individual ORs by the inverse
of their variance. For each analysis, the final effect OR and 95%
CI were obtained by means of both random and fixed effect
models. The selection of the computational model was done based
on the expectation that the studies shared a common effect size.
The random effect model was preferred because it accepts that
there is a distribution of true effect sizes rather than one true effect
and assigns a more balanced weight to each study. It was also used
because all the studies were considered to be unequal in terms of
specific ADs.
Heterogeneity was calculated by means of Cochran’s (Q) and
Higgins’s (I2) tests. The I2 test showed the proportion of observed
dispersion that was real rather than spurious and was expressed as
a ratio ranging from 0% to 100%. I2 values of 25%, 50%, and
75% were qualitatively classified as low, moderate, and high
respectively. A significant Q-statistic (p,0.10) indicated heteroge-
neity across studies. Publication bias was determined using Funnel
plots and Egger’s regression asymmetry tests, and additional tests
were applied if it was found.
Results
The search with the defined MeSH Terms in PubMed,
SCOPUS, SciELO, and LILACS [DeCS Terms] retrieved 531
articles. Using text words, 794 articles were found in PubMed,
SCOPUS, SciELO and LILACS. Nine additional records were
identified through references (Figure 1).
After duplicates were removed, there were 575 potentially
relevant articles. Based on title or abstract, 143 were chosen for full
text review. Six full text publications were not found and the
authors of these publications or authors of publications that
referenced them (e.g. [22]) were contacted. Of these, 4 articles
were sent via e-mail [23–26] and one by post mail [27]. It was not
possible to get full text access to one article [28]. One hundred and
three articles described exposure to OSs as a category and used
accepted classification criteria for ADs. Of these, 3 were meta-
analysis [29–31], 29 were reviews, 5 case series [32–36], 15 case
reports [37–51], and 51 epidemiological studies. Thirty-three of
the epidemiological studies were finally included in the meta-
analysis (Table 1) [7,23,26,27,52–80]. Because of lack of
information, 18 epidemiological studies [25,81–97] were not
included in the meta-analysis (Table S1). Eight studies were not
included because lack of information about the number of subjects
with confirmed AD; two case-control studies were not included
because lack of information about exposure in control subjects;
one case-control study was excluded because control subjects had
likely an AD diagnosis; three cohort studies were not included
because lack of information about the number of unexposed and
how many developed AD. Four studies were excluded because
exposure data had low specificity for OS.
Types of exposure and exposure assessments are described in
table 1 for each study. The average qBHs for the total publications
included in the meta-analysis was 14.25 points (SD, 1.586; range,
11–17 points; 99% CI, 13.528–14.972) reflecting a categorical
rating of moderate relationship.
We found a significant association between OSs exposure and
the increased risk of developing an autoimmune trait by evaluating
all ADs as a single group. Figure 2 shows the forest plot
corresponding to the meta-analysis including the most relevant
outcome per author where the final common effect size based on a
random model was statistically significant (OR: 1.54; 95% CI:
1.25–1.92; p-value,0.001). The results of different measures for
heterogeneity calculated for the analysis showed in Figure 2 were
as follows: Q-value: 132.1; degree of freedom (Q):30; p-
value,0.0001; I-squared: 77.3%; Tau-Squared 0.19. The relative
weight of each study is included in the forest plot (Figure 2)
There were 5 studies showing complex data structure with
different and non-cumulative results where the information for the
different effects was not totally independent [52,57,70,76,78].
Then, 22 additional meta-analyses including 30 articles and the
different outcomes of four of the above mentioned studies were
calculated independently [57,70,76,78]. These analyses included
five from Diot et al. 2002 [76] (different toxic exposure measured:
chlorinate, ketones, aromatic, toluene, TCE), one from Nelson et
al. 1994 [57] (control not disabled population) and Purdie et al.
2011 [70] (a different cutoff point to disease criteria) and fifteen
from Thompson et al. 2002 [78] (different toxic exposure
measured: toluene, benzene, white spirit, perchlorethylene, TCE,
trichlorethane, vinyl chloride, urea formaldehyde, meta-phenyle-
nediamene, bicromade, aromatic hydrocarbons, aliphatic hydro-
carbons, fenfluramine, diethylpropion, L5 OH-tryptophan). In
these meta-analyses, the studies that provided uniquely RR data
were not included [52,54] for statistical reasons. All these
additional meta-analyses showed a significant association between
the exposure to OSs and ADs as a trait (Figures S1, S2, S3, S4, S5,
S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19,
S20, S21, S22). After doing a sensitivity analysis excluding one
study at a time, the results were similar to the cumulative analysis
(Figures S23 and S24).
A second effect size was calculated based on data from two
studies showing RR data [52,54] with raw data from cohort
Organic Solvents and Autoimmune Diseases
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studies [26,55,56,63–66,70]; this effect size was not significant
(OR: 1.62; 95% CI: 0.99–2.65; p-value:0.051) (Figure S25). The
results of different measures for heterogeneity calculated for the
analysis showed in Figure S25 were as follows: Q-value: 42.01;
degree of freedom (Q):11; p-value,0.001; I-squared: 73.8%; Tau-
Squared 0.40.
Additional analysis limited to the association between each
specific AD and OSs exposure presented significant associations in
the random model. For MS, the OR was 1.53 with 95& CI 1.03–
2.29 and p value: 0.035, with fifteen studies included. For primary
systemic vasculitis (PSV), the OR was 3.15 with 95% CI: 1.56–
6.36 and p-value: 0.001, with one study included in the cumulative
analysis for this disease. Systemic sclerosis (SSc) showed these
Figure 1. Systematic Review Results. Footnote: OSs: organic solvents; AD: autoimmune disease; OR: odds ratio.
doi:10.1371/journal.pone.0051506.g001
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Table 1. Characteristics of the studies examined in the meta-analysis.
First author and
year of
publication AD Study population and control group Assessment of exposure Outcome
qBHs (max.
score 21)
-Country - Method used to get the information
(questionnaire, database)
-Method used to identify cases
and controls-Number (N).
- Terms of the exposure estimate
(qualitative, semi-quantitative,
quantitative indirect)
-Study design -Type of exposure
Lundberg
et al. 1994 [52]
AS RA Sweden. From the computer-based
census was extracted a cohort according
to the occupational status ten years
before the observation. N = 375,035 men
and 140,139 women. Using the hospital
discharge register the study population
was observed from 1981–1983 and
rheumatoid diseases cases extracted.
N = 896 males and 629 females for RA;
79 males and 13 females for AS; for
myositis 23 males and 14 females; for
SSc 47 males and 24 females; 36 males
and 57 females for SLE, 31 males and
6 females for vasculitis. Study design:
retrospective cohort.
Job-exposure matrix with two categories of
intensity for OS (semi-quantitative). Substantial
use designated occupations where the average
amount of solvent handled per year was
estimated to 100 litters or more, e.g. house
painters. Limited use designed occupations in
which average amount of solvent handled
was estimated 1–99 litters, e.g. house
carpenters.
Increased
relative risk
for workers
in occupations
with substantial
use of OS.
Painters showed
increased
isk for AS.
16
Fored et al.
2004 [53]
GN Sweden. Cases identified from the
NPR (1996–1998) men and women
whose creatinine level exceeded 300
mmol/L and 250 mmol/L, respectively,
physicians at each hospital treating
patients determined case eligibility by
reviewing medical records N = 217.
Control subjects randomly selected
from the NPR and frequency-matched
according to age and gender. Study
design: population based case-control
study.
Face to face interview by occupational
hygienists (not blinded). Senior occupational
hygienist estimated the intensity and
cumulative lifetime exposure to OS using an
accepted rating and arithmetic method
(quantitative indirect). Seventy percent of the
case patients and 62% of the control subjects
reported exposure during manufacturing
work, largest group: metal workers.
Adjusted OR
0.96
(95% CI
0.68–1.34)
12
Sesso et al.
1990 [54]
GN Brazil. Cases: 17 patients with
rapidly progressive GN associated
with OS exposure and 34 matched
hospital controls. Renal histologic
findings suggest immune complex
mediated injury. Study design:
Case-control.
Self-report OS exposure (qualitative) was
defined as 1 hour or more weekly for 3
consecutive months or longer. Increased
risk was detected in exposed to fuels.
Relative
risk = 5
(95% IC
1.14–22)
15
Flodin et al.
2003 [55]
MS Sweden. Cases were identified among
The Nurse Union through an appeal
published in the union magazine. The
occupational group they focused was
Nurse anesthetists. Among the subjects
who replied, Nurse anesthetists with MS
diagnosis were identified. To confirm MS
medical files were requested N = 10.
Study design: retrospective cohort.
A questionnaire requested qualitative
information about years and kind of
work tasks, and type of anesthetics they
had used.
Increased
MS risk was
detected
in nurse
anesthetists.
17
Stenager et al.
2003 [26]
MS Denmark. In a nationwide study on the
isk of MS in Danish nurses were identified
nurse anesthetists with confirmed cases
of MS. Expected number of MS was
calculated in an age- and sex-matched
population. Study design: retrospective
cohort.
Qualitative data was assessed using
a national register of nurses and the
Danish Multiple Sclerosis Register.
Nurse
anesthetist
had no
increased risk
11
Amaducci et al.
1982 [56]
MS Italy. Cases were identified from a register
of MS patients and interviewed to
establish their last occupation before
the disease onset. Five cases of MS were
employed in shoe and leather industry.
Relative risk was calculated between
shoe and leather workers and the
general population of Florence. Study
design: retrospective cohort.
Data on general population and
people employed in the shoe and
leather industry of Florence were
obtained from Census.
Increased
risk among
shoe and
leather
industry
workers (4.81)
13
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Table 1. Cont.
First author and
year of
publication AD Study population and control group Assessment of exposure Outcome
qBHs (max.
score 21)
Nelson et al.
1994 [57]
MS USA. Cases identified by reviewing
medical records of employees taking
medical disability at any of eight
automobile assembly plants located in
Michigan and Ohio N = 20. Controls
chosen from employees who took
disability retirement for disorders
other than those of interest. Study
design: Case- control.
Semi-quantitative exposure
indices were assigned by two
industrial hygienists and expressed
in years working in solvent
exposed tasks.
OR 2.0
(95% CI 0.6–6.9)
15
Grønning et al.
1993 [58]
MS Norway. Cases were patients living in
Hordaland with clinical MS onset
between 1976–86 N = 139. Controls
comprised patients admitted to the
hospital with other diagnosis matched
on age, sex and residence N = 161.
Distributions among type of work and
type of OS were similar among cases
and controls. Study design:
case- control.
Face to face questionnaire that elicited
detailed information about exposure
to OS and number of years of exposure.
Exposure index was calculated using
Ravnskov formula (quantitative indirect).
Main occupational exposure to OS
occurred at mechanical, oil, textile,
wood-working, paint, printing, plastic
and rubber industries.
OR 1.55
(95% CI 0.83–2.90)
15
Zorzon et al.
2003 [59]bc
MS Italy. Cases were consecutive patients
who were being seen in routine
follow-up at the Multiple Sclerosis
Center of the University of Trieste
N = 140. Control group was formed
by sex and age matched blood donors
N = 131. Controls were similar to
cases in area of residence and
ethnicity. Study design: case- control.
Face to face interview (blinded)
collected detailed information related to
occupational exposures (qualitative).
Exposure was considered when lasting
.5 years.
OR 0.8
(95% CI 0.5–1.4)
14
Juntunen et al.
1989 [60]
MS Finland. From the Finish Twin
Cohort 21 cases of MS were
extracted and records reviewed
by a neurologist. Only 2 pairs
were concordant. The comparison
group was formed by the co-twins.
Study design: Nested case control.
Face to face interview by a specialist
on occupational medicine. Exposure
was estimated and roughly classified
(semi-quantitative).
No statistically
significant
association of
exposure.
13
Flodin U
et al.
1988 [27]
MS Sweden. Cases were obtained from
the patient files of the neurologic
clinics of the General Hospital of
Linko¨ping N = 83. Control group
was already available as primarily
utilized for cancer studies, and
randomly drawn from the
population registers N = 467.
Study design: Case- control.
Mailed questionnaire. A minimum
criterion of one year was required
for exposure time. Semi-quantitative
score was obtained based on Ravnskov
method.
Mantel-Haenezel
Rate Radio
2 (90% CI 0.9–4)
14
Koch-Henriksen
et al. 1989 [61]
MS Canada. Case group N = 187.
Control group N = 187. Case-
ascertainment and selection of
controls: NA. Study design:
population based case-control study.
Questionnaire about industrial OS
exposure (qualitative).
No significant
association
14
Casetta et al.
1994 [23]
MS Italy. Cases: definite MS patients
living in the province of Ferrara
N = 104. Two matched control
groups, one from hospitalized
patients and the other from
general population. Study design:
Case- control.
Face to face blind interview about
occupational history before the age
of onset (qualitative).
OR 4
(95% CI
1.48–11.11)
14
Landtblom
et al. 1993 [62]
MS Sweden. Cases collected from the
files of the neurological department
of the hospitals Jo¨nko¨ping and
Kalmar N = 91. Controls were
randomly drawn from population
registers of the administrative
provinces of Jo¨nko¨ping and Kalmar
N = . Study design: population
based case-control study.
Mailed questionnaire focused on
occupational exposures. A minimum
criterion of one year was required for
exposure time. Semi-quantitative score
was obtained based on Ravnskov method.
Mantel-Haenszel
Rate Radio
2.8 (95% CI 0.9–8)
15
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Table 1. Cont.
First author and
year of
publication AD Study population and control group Assessment of exposure Outcome
qBHs (max.
score 21)
Landtblom
et al. 2006 [63]
MS Sweden. From the 1985 census
were identified nurse anesthetists
(N = 907) and compared to other
nurses (N = 39,703) and teachers
(N = 20,053). Age restriction to the
interval of 35–50. Cases: MS diagnosis
or disability pension due to MS
(N = 168). Study design:
retrospective cohort.
In the census each person had to
declare which occupation held.
Based on this information nurse
anesthetists, potentially exposed
to OS, were identified (qualitative).
Cumulative
incidence rate
ratio was
increased in
female nurse
anesthetists
(statistically no
significant)
15
Mortensen
et al. 1998 [64]
MS Denmark. From the 1970 census
‘‘solvent-exposed men’’ group was
extracted N = 124,766. ‘‘Unexposed
men’’ cohort comprised electricians,
bricklayers, and butchers N = 87,501.
After a 20 years of follow-up 87 MS
cases presented among presumed to
be exposed. Study design: cohort.
Census contains information of the
occupational status and qualitative
data of exposure. House painters,
carpenters, and typographers are the
occupations with the longest exposure.
There was no
important
difference in the
standardize
morbidity ratio
between
occupational
groups.
14
Riise et al.
2002 [65]
MS Norway. Three cohorts of 11,542
painters; 36,899 construction workers
and 9,314 food-processing were
followed from 1970 to1986. A total
of 9 painters, 12 construction workers
and 6 food-workers received pension
because of MS. Study design: cohort.
Workers potentially exposed to OS
(qualitative data) were identified by
the 1970 national census.
The relative risk
95% CI for
painters compared
with workers not
exposed to OS
was 2
15
Riise et al.
2011 [66]
MS Norway. From the Registry of
Employers and Employees was
extracted a cohort of 27,900 offshore
petroleum workers, 42,657 onshore
petroleum workers and 365,805
referents. The total cohort was
linked to the nationwide Norwegian
MS registry including all cases of MS
with onset after the start of their
working engagement. Study design:
retrospective cohort.
Offshore workers of the petroleum
industry with suspected OS exposure
(qualitative data) included technicians,
laboratory engineers and control
operators involved in the production
process and ‘drilling and well
maintenance offshore’.
There was no
increased risk
of MS among
offshore workers
12
Gershwin
et al. 2005 [67]
PBC USA. Between November 1999 and
June 2004 a total of 1,090 patients
with PBC were refereed from 23
referral medical centers. Referring
physicians re-evaluated anonymized
clinical information in 100 randomly
selected enrolled patients. Controls
were selected by random digit dialing
and matched for sex, age, race, and
geographical area. Study design:
case-control.
Telephone interview included over
180 questions and 300 sub-questions,
including exposure data (semi-quantitative).
PBC patients reported to use hair dye
38650 times/year and nail polish
29665 times/year.
A history of
nail polish was
associated with
PBC AOR 1.002
(95% CI
1.00–1.003).
15
Lane et al.
2003 [68]
PSV UK. Cases: PSV diagnosed between
May 1988 and july 2000 identified
from a prospective vasculitis register.
Case notes were reviewed for clinical
and laboratory details N = 103.
Controls N = 220 hospital inpatients
and outpatients with non-inflammatory
musculoskeletal disease, matched to
the age of the case at the time of
interview. Controls were excluded if
personal history of AD. Study design:
case –control.
Face to face structured questionnaire.
To defined occupational OS exposure
was used the Steenland job exposure
matrix (quantitative indirect).
A history of OS
was associated
with PSV; OR 2.7
(95%IC 1.1–6.6) a
nd WG 3.4 (1.3–8.9)
15
De Roos et al.
2005 [69]
RA USA. The Agricultural Health Study
is a cohort of licensed pesticide
applicators and their spouses. From
this cohort RA diagnosis were
validated among women who had
self-reported RA, N = 136 physician-
confirmed cases were matched by
age to 5 controls. Controls were
selected from among women in the
cohort except those who had
reported any AD. Study design:
Nested case-control.
Information was available from the
Agricultural Health Study
questionnaires (qualitative).
Risk of RA was
not associated
with OS; OR 0.6
(95% CI 0.3–1.5)
14
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Table 1. Cont.
First author and
year of
publication AD Study population and control group Assessment of exposure Outcome
qBHs (max.
score 21)
Purdie et al.
2011 [70]
RD New Zeeland. Technicians, scientist,
and laboratory assistants working in
medical laboratories were assessed
for RD using the UK Scleroderma
Study group questionnaire. RD rates
in solvent-exposed histology, cytology,
and transfusion medicine (N = 301)
were compared with unexposed
medical laboratory workers from
transfusion medicine. Study
design: retrospective cohort.
Laboratory workers self-report history
of exposure to OS including frequency
and years working (semi-quantitative).
Higher rates of RD, particularly, for those
who had worked with xylene, toluene or
acetone.
OR 8.8 (95%
CI 1.9–41.1)
16
Cooper et al.
2004 [71]
SLE USA. Cases: Carolina Lupus
Study included resent diagnosed
patients identified through community
based rheumatologist practices
in the study area N = 265. Population
based controls were identified through
driver license records and were f
requency matched to the cases
by age, sex, and state N = 355.
Study designed: case-control.
In 60 minutes in person interview, job
history and specific questions about
potential exposure were asked. Three
reviewers (one industrial hygienist and
2 epidemiologist) reviewed the job and task
description and qualified the exposure in
5 categories (likely-high, possible-high,
possible-moderate, indirect, none).
There was no
evidence of
association
between
occupational
exposure to OS
and SLE
11
Cooper et al.
2010 [72]
SLE Canada. Cases: recruited from 11
rheumatology centers across
Canada N = 258. Control randomly
selected from phone number listings
and matched by age, sex, and area of
residence N = 263. Study design:
case-control.
30–45 minutes telephone interview
assessed work history and specific potential
exposures (qualitative). Strong associations
were seen with work as an artist working
with paints, dyes or developing film (1),
and applying nail polish (2).
(1) OR 3.9 (95%
1.3–12.3)
(2) OR 10.2 (95%CI
1.3–81.5)
15
Finckh et al.
2006 [7]
SLE USA. cases: women with SLE were
identified through both community
screening and hospital data-bases
in 4 predominant African American
neighborhoods N = 95. Controls were
female residents of the same area
who participated in one of the
screening events but were negative
for SLE N = 191. Study design:
population based case-control.
Data were collected using in-person
interviews (qualitative). A detailed lifetime
work history followed by a structured
checklist involving specific jobs likely to
involve exposure to solvents (e.g. wood
finishes, paints, dry-cleaning, pottery).
OR 1.04
(95% 0.34–3.2)
13
Nietert et al.
1998 [73]
SSc USA. Cases: From March 1995 to
February 1997 were included
patients being seen in the
rheumatology clinics N = 178.
Controls diagnosed with
osteoarthritis, gout and
fibromyalgia were selected
during the same time period
N = 200.
Study design: case-control.
Data were collected using in-person
nterviews. Semi-quantitative score were
assigned by computerized method,
based on the occupational and
industrial classification.
OR 2.9
(95% CI 1.1–7.1)
15
Bovenzi et al.
1995 [74]
SSc Italy. Cases: from the computerized
admission files of all of the local
hospitals from 1976 to 1991 N = 21.
Clinical records were obtained and
verify. With the same database system,
for each case, 2 age and gender
matched referents. Study design:
case-control.
Blinded interview with a structured
questionnaire, which included exposure
to OS. The subjects were allocated into
the various exposure categories (semi-
quantitative) by 2 occupational physicians
who were blinded. Minimum criterion of six
months was required for exposure duration.
OR 9.28
(95% CI 0.48–74.1)
for men; 2.11
(0.20–22.0)
for women
16
Bovenzi et al.
2004 [75]
SSc Italy. Cases: N = 55 (46 female,
9 male) recruited at Institute of
Internal Medicine of University of
Hospital Verona, patients affected
with localized scleroderma were not
included. Controls N = 171 among
patients admitted in the same study
period to the Institute of Orthopedics
with other diagnosis different to any
AD. Study design: case-control.
In-person interview and structured
questionnaire focused on occupational
history. Explicit questions referenced to
potential exposure to OS. The occupational
history was reviewed and qualified (semi-
quantitative) by an expert in industrial
hygiene and occupational health, blind to
case-control condition.
Female teachers
OR 3.4
(95% CI 1.2–10.1)
Textile workers
OR 2.1
(95% CI 1.0–4.6)
14
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results OR: 2.54; 95% CI: 1.23–5.14; p-value: 0.011, with eight
studies included (Figure 3). Primary biliary cirrhosis (PBC) was
positively associated but not statistically significant (OR: 1.002;
95% CI: 1–1.004; p-value: 0.092).
The analyses according to the exposure assessment category are
shown in figure S26. There were three groups included. Two of
them were not significant: qualitative (OR: 1.29; 95% CI: 0.84–
1.98; p-value 0.231) and quantitative indirect (OR: 1.69; 95% CI:
0.90–3.16; p-value 0.101) and one was significant: semi-quantita-
tive [(OR: 1.48; 95% CI: 1.17–1.87; p-value 0.001). Heterogene-
ity: Q-value: 56.7; degree of freedom (Q):13; p-value,0.0001; I-
squared: 77%; Tau-Squared 0.19]. The total heterogeneity
between the three groups for the random effects analysis was not
significant [Q-value: 0.60; degree of freedom (Q):2; p-value: 0.741]
Evidence of significant publication bias was identified using the
Egger test (p-value 2-tailed: 0.002; intercept: 1.09) for the meta-
analysis which included studies that report OR with its respective
95% CI and raw data from case control and cohort designed
studies. The Funnel plot showing the standard error on the Y axis
is shown in Figure S27. Therefore, a second analysis was run in a
search for publication bias. The classic fail-safe analysis indicated
that 279 missing studies would give a p-value of .0.05. Begg and
Mazumdar rank correlation was not significant (p-value 2-tailed:
0.16) and the trim and fill adjustment did not suggest a lower risk
than the original analysis [adjusted values (11 studies trimmed)
point estimate 1.03 (0.83–1.28), Q value: 227]. Based on all the
analyses for publication bias, we consider the impact of bias in the
present meta-analyses trivial.
Since 1977, 20 publications including case-reports and case
series (Table S2) have reported 37 cases of AD possibly being
triggered by OSs. We also found 3 previous meta-analyses. The
first was published in 1996 by Landtblom AM et al [29] and
concerned OSs exposure as a cause of Multiple Sclerosis (MS).
They found 13 studies and reported an overall RR of 1.7 (with a
Table 1. Cont.
First author and
year of
publication AD Study population and control group Assessment of exposure Outcome
qBHs (max.
score 21)
Diot et al.
2002 [76]
SSc France. Cases admitted consecutively
to the department of Internal
Medicine from 1998 to 2000 N = 80.
For each case, two age, gender, and
smoking habits (frequency and
quantity) matched controls. Study
design: case-control.
A semi-quantitative score were calculated,
by a committee of six experts, based on
probability, intensity, daily frequency, and
duration of exposure for each period of
employment. Final cumulative score was
obtained.
Significant
associations were
observed for TCE,
toluene, aromatic
solvents, ketones,
white spirit, epoxy
resins and welding
fumes.
15
Maıˆtre et al.
2004 [77]
SSc France. Cases: 10 men and 83
women diagnosed between 1995
and 1999 and 206 age and sex
matched controls, randomly
selected from general population.
Study design: case-control.
Mailed questionnaire and phone interview.
The questions included occupational details
and suspect forms of exposure. Every job
was classified by a group of experts
according to the potential level of
exposure on a 3-level scale (semi-
quantitative). The criteria used for
this classification were likelihood,
duration, intensity and percentage of
working time exposed.
Solvents were
linked to
SSc OR 3.2
(95% CI 1.5–6.6)
in both men
and women
15
Thompson
et al. 2002 [78]
SSc Canada. Cases: N = 91 patients
identified in a rheumatology
outpatient practice. Controls
N = 154 derived from the same
practice, same rheumatologist,
and matched by age and sex,
did not have SSc. Study design:
case-control.
Mail questionnaire with specific
questions of employment information
and chemical exposure (semi-quantitative)
at workplace or home. Exposure rates in
both groups were low.
There were no
differences in
type of
employment
between the
2 groups.
11
Silman et al.
1992 [79]
SSc UK. Cases recruited from
registers of patients with
SSc from different centers,
N = 56 men. Controls: (1) patients
were asked to provide three male
friends within 5 years of age and
(2) general practitioner was
approached to provide the
names of three male patients,
age matched. Study design:
case-control.
Postal questionnaire for self-report
exposure. Occupational exposure was
assessed in two ways. First, detailed
history of occupations was assessed,
blinded to the case or control status,
by an experienced occupational
hygienist and scored (semi-quantitative)
for nil, possible, or probable exposure.
Secondly the subjects were asked to
recall exposure to a detailed list of
solvents.
No significant
increase in
exposure to
OS was noted.
13
Czirja´k et al.
1989 [80]
SSc Hungary. Cases from hospital
data N = 61, with controls
matched for age and sex.
Study design: case-control.
Self-reported exposure (qualitative) to:
benzene, isopropyl alcohol, ethyl acetate.
Risk related to length of exposure but
not data on risk by intensity.
OR 23.18
(95%
CI 2.97–180.79)
17
AD: autoimmune disease, qBHs: Quantitative score of the Bradford Hills Criteria for causation. AS: ankylosing spondylitis. RA: rheumatoid arthritis. SSc: systemic sclerosis.
SLE: systemic lupus erythematous, OS: Organic solvent. GN: glomerulonephritis,NPR: National population Register; N: number of subjects in each group. OR 95% CI:
Odds ratio with 95% confident interval. MS: multiple sclerosis. NA: not available data. PBC: primary biliary cirrhosis. AOR: Adjusted odds ratio. PSV: primary systemic
vasculitis, WG: Wegener’s granoulomatosis. RD: Raynaud’s disease. TCE: trichloroethylene.
doi:10.1371/journal.pone.0051506.t001
Organic Solvents and Autoimmune Diseases
PLOS ONE | www.plosone.org 9 December 2012 | Volume 7 | Issue 12 | e51506
95% CI of 1.1–2.4). Later in 2001, Aryal BK et al [30] published a
meta-analysis of SSc and solvent exposure. Eight studies met
inclusion criteria, and the RR was reported to be 2.91 (with a 95%
CI of 1.60 to 5.30). Kettaneh A et al in 2007 [31] published the
most recent meta-analysis about occupational exposure to solvents
and gender-related risk of SSc, they found a statistically significant
association of SSc with OS exposure (OR 2.4; 95% CI 1.7–3.4:
P = 0.002) and concluded that whereas SSc affects women
predominantly, among subjects with occupational exposure to
OS, men are at a higher risk of developing the disease than
women. All the studies included in these publications were
examined in our analysis. No meta-analysis evaluating ADs as a
trait was found.
Regarding the systematic search for the OSs molecular
mechanisms related to responses of immune system and ADs,
with defined MeSH Terms and text words, retrieved 893 articles.
After duplicates were removed, we obtained 827 articles of which
86 were included according to the inclusion criteria. The results
are described in detail in Tables S3 and S4 and inclusion/
exclusion criteria are described on Figure S28. Table 2 shows
selected articles, representing main molecular processes related
with OSs exposure and their potential implication on immune
system or autoimmune pathologies. We found that the effects of
OSs on the immune system include lymphoproliferation, autoan-
tibody production, Th1 and Th17 responses, oxidative stress,
protein modification as well as effects on gene expression.
Discussion
Our results indicate that OS exposure is a risk factor for
developing ADs. Even though the individual meta-analyses (i.e.
each AD considered separately) disclosed significant association for
MS, PSV and SSc (Figure 3), the direction and significance of this
association did not change when all ADs, considered as a single
trait, were analyzed (Figure 2).Different combinations of factors
involved in the generation of autoimmunity produce diverse
clinical pictures within the wide spectrum of ADs (mosaic of
autoimmunity) [2]. Our study, which takes into account both OSs
as a whole and each solvent separately, reinforces this as well as
the fact that ADs might share several common mechanisms(i.e.,
the autoimmune tautology) [98]. However, the term ‘‘separately,’’
which is used to refer to the studies that analyze only one solvent,
is not the most biologically appropriate because most of the
solvents are a mixture [99].
Our meta-analysis with ORs as the measure of association
including 31 articles regarding 8 ADs showed a significant
relationship of OSs exposure with ADs (OR: 1.54; 95% CI:
1.25–1.92; p-value,0.001) and that with RRs as the measure of
association including 10 articles and 5 ADs showed a near
significant relationship (OR: 1.62; 95% CI: 0.99–2.65; p-
value:0.051). When each AD was considered individually, there
were also significant results with MS, PSV, SSc and PBC, although
the latter was positively associated but not statistically significant.
A systematic and comprehensive review of the effects of OSs on
the immune system is shown in Table 2. OSs are capable of
altering cellular proliferation, apoptosis and tissue-specific function
[100–126]. Both the amount and duration of OSs exposure are
Figure 2. Forest plot of studies meta-analyzed: association between organic solvents and autoimmune disease as a trait. Footnote:
final common effect size based on a random model. Odds Ratio (95%CI) with raw data from case control and cohort designed studies were included.
The most relevant outcome per author was included. The relative weight of each study is included. GN: glomerulonephritis; MS: multiple sclerosis;
PBC: primary biliary cirrhosis; PSV: primary systemic vasculitis; RA: rheumatoid arthritis; RP: Raynaud disease; SLE: systemic lupus erythematosus; SSc:
systemic sclerosis. Diot, et al 1: organic solvent as a whole; Thompson AE, et al 1: turpentine exposure (the most significant result); Nelson NA, et al 1.
1994: disabled population; Purdie GL, et al 1. 2011 confirmed RP population.
doi:10.1371/journal.pone.0051506.g002
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essential in pathology causation. Chronic exposure to OSs might
lead to deposits in an organ and consequently to immune
infiltration, similar to what is observed in ADs. The self-proteins
that are modified by OSs may become immunogenic, recognized
as foreign, and then initiate an inflammatory response and tissue
injury. In this regard and according with our results, there are
similar pathways operating on the incidence of ADs, but there are
also specific mechanism that could lead to the particular
manifestations of each AD; for instance, lymphocyte infiltration
and immunoglobulin’s deposits in SLE, and enzymatic alteration
and scleroderma-specific antibody subsets in SSc [86,106,109].
Ketones are the most common OS used by the general
population. Acetone, the simplest example of the ketones, is a
commonly used solvent and is the active ingredient in nail polish
remover and some paint thinners. It has been suggested that nail
polish use may be associated with PBC [67]. These data are
intriguing in view of the xenobiotic hypothesis proposed for the
development of PBC with specific halogenated compounds. These
compounds could increase the immunogenicity of mitochondrial
proteins and induce anti-mitochondrial antibodies in animal
models [127]. In fact, only one clinical study was included in the
meta-analysis regarding PBC and nail polish exposure disclosing a
positive associated but not statistically significant [67]. More
studies involving PBC patients searching for this association could
be useful.
Long term exposure to OSs seems to foster massive hepatic
mononuclear infiltration leading to autoimmune hepatitis al-
though it is important to highlight that this infiltration is the first
step in the immunopathogenesis of not only autoimmune hepatitis
but also the rest of the ADs [108]. As shown by Cai et al [109],
lymphocyte infiltration was found in the pancreas, lungs, and
kidneys in addition to the liver.
In autoimmune thyroid disease, it is probable that solvents may
interfere with iodine transportation and induce oxidative stress
that leads to an inflammatory response to the thyroid gland [128].
The relevance of our results rely in the fact that relation
between SSc and environmental exposure, especially involving
OSs is significant. Mice MRL+/+, an autoimmunity susceptible
Figure 3. Forest plot of studies meta-analyzed grouping by comparison of specific autoimmune diseases. Footnote: random effect
model showing significant association between SSC and OSs exposure. PBC and PSV included only one study (100% of the weight). Q value for SSc
analysis: 33.7, I2:79,2, Degree of freedom (Q):7, p-value,0,0001. GN: glomerulonephritis; MS: multiple sclerosis; PBC: primary biliary cirrhosis; PSV:
primary systemic vasculitis; RA: rheumatoid arthritis; RP: raynaud disease; SLE: systemic lupus erythematosus; SSc: systemic sclerosis. Diot, et al 1:
organic solvent as a whole; Thompson AE, et al 1: turpentine exposure (the most significant result); Purdie GL, et al 1: confirmed RP population;
Nelson NA, et al 1. 1994: disabled population.
doi:10.1371/journal.pone.0051506.g003
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strain, when exposed to TCE increase the total IgG serum
concentration, antinuclear antibodies (ANAs) and anticardiolipin
autoantibodies [100]. On the other hand, in an in vitro model of
human epidermal keratinocytes, was possible to determinate that
TCE not only stimulates reactive oxygen species release, but also it
stimulates nitric oxide synthesis by nitric oxide synthase. These
cellular changes may contribute to the physiopathological process
that lead to skin injury such as shown in SSc [106]. The biological
mechanisms by which OSs may induce the development of ADs
support the results observed trough the meta-analysis.
Concerning MS, when an independent analysis was done for
each disease, MS show a significant association with OSs
exposure. These results are like those reported by Landtblom et
al [29], in their 1996 meta-analysis. Landtblom et al implemented
a Mantel-Haenszel RR calculation. The main differences between
their analysis and ours rely on the statistical approach because the
Mantel-Haenszel method for combining OR is an alternative to
the fixed-effect inverse variance method and we developed a
random effect model. Our meta-analysis included 15 MS studies, 7
new to the previous meta-analysis [26,55,59,63–66] published
between 1994 and 2012.
The precise mechanisms responsible for the development of
environmentally-induced autoimmune disorders are unknown.
Although many hypotheses for the occurrence of autoimmune
phenomena after various environmental exposures have been
proposed, none of the hypotheses is completely supported by
direct causal evidence. Also, mechanisms thought to be involved in
the initiation of the disease process might differ from the
mechanisms believed to exacerbate an established illness. Howev-
er, the experimental approaches have been able to identify
different environmental factors that use the same toxicity paths
and mechanisms and either individually or jointly can have strong
effects on molecular signaling pathways, immune responses or
regulation mechanisms actively involved in health and disease
(Figure 4 and Table 2).
It could be suggested that, as described for autoimmune/
inflammatory syndrome induced by adjuvants, the toxic effect
Table 2. Effects of the exposition to organic solvents on experimental models.
OS EFFECTS ON PHENOTYPE REFERENCES
TCE - DCAD Lymphoproliferative reaction, ANAs and anti-cardiolipin
autoantibodies production (Mouse).
[100]
TCE, PCE Protein modification, TCE binds covalently with some
proteins or lipids and form adducts (Rat, Mouse).
[101][102][103][104][105]
TCE Splenocytes of mice treated with TCE secreted higher levels of
IL-17 and IL-21. Protein adducts stimulate the activation of Th17 cells.
[125]
TCE Production of ROS and NO, activation T cells; cellular infiltration
(Mouse, Human Keratinocytes).
[109][111][126]
TCE The low exposure to TCE generates a Th1-like cytokine responses
and ANAs production; High-Exposure, increase CD44high T cells
subsets with ability of IFN-c secretion and cellular infiltration (Mouse).
[107]
TCE Increase of CD4+ and CD8+ T cells population (Mouse). [110]
TCE Inhibition of cellular apoptosis of naive CD4+ and CD8+ T cells
subset; anti-histone autoantibodies production (Mouse).
[111]
TCE-TCAH Inhibition of lymphocyte apoptosis in the thymus through
decrease FasL or peripheral lymphocyte (Mouse).
[112]
TCE + HgCl2 Anti-Hsp90 autoantibodies and antibodies against liver
proteins production (Mouse).
[114]
TCE2DCVC High-doses cause cellular necrosis. Low-doses produces changes
in the transcription of several genes involved in apoptosis and
cellular proliferation (Human).
[115]
TCE Low-doses cause DNA-hypermetylation on cardiac myoblasts (Rat). [116]
Benzene Decrease of T cells population (cellular immunity)
(American kestrels Birds).
[117]
Benzene Decrease in number of CD4+ and CD8+ T cells, B cells,
granulocyte and platelets (Human).
[118]
Benzene Increase of ROS production and induction
of DNA-fragmentation (Human).
[119]
Benzene Changes in gene transcription involved in apoptosis, oxidative
stress, cellular cycle and cytokine production (Mouse).
[121]
Toluene High-doses affect the IFN-c, IL.-4 and IL-13 production by
T cells and increases TNF-a expression (Human PBMCs).
[122]
Toluene-hexane- Methyl ethyl Ketone Produce oxidative stress (Human Jurkat Cells). [123]
TCE –Benzene- HgCl2 Changes in gene expression with effects on cellular
proliferation, apoptosis and tissue-specific function (Rat).
[124]
In parenthesis is shown the model where the effect was studied. OS: Organic solvent; TCE: Trichloroethylene; DCAC: dichloroacetyl chloride; TCAH:
Trichloroacetaldehyde hydrate; HgCl2: Mercuric Chloride; DCVC: dichlorovinyl-l-cysteine; PCE: Perchloroethylene; ROS: Reactive Oxygen Species; NO: Nitric Oxide; ANA:
Anti-Nuclear Antibodies; TNF-a: Tumor Necrosis Factor alpha; IFN-c: Interferon Gama; IL-4: Interleukin 4.
doi:10.1371/journal.pone.0051506.t002
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influences the appearance of these conditions only in subjects who
are genetically susceptible [13].
Study Limitations
Significant differences between case-control and cohort models
were found. This fact can be explained by the limitations of each
of these methodologies [129]. The following are the limitations in
case-control studies. (I) the information about exposure is
primarily based on interviews and may be subject to recall bias.
(II) Validating the information on exposure can be difficult or even
impossible. (III) By definition, case-control studies evaluate a single
disease. (IV) The selection of an appropriate control group might
be difficult. Most of the studies ignored the common origin of ADs
and this generates the possibility of including patients with an
underlying autoimmune condition as controls.
Most of the cohort studies included in our meta-analysis were
retrospective. This implied that: (I) data was collected before the
research hypothesis was defined leading to inaccurate data for the
research. (II) The crude information was taken from databases or
census. Therefore, the report on the exposure is not a direct
quantification of the exposure. (III) The outcome information
came from databases or medical records, but the subjects were not
examined and this can lead to misdiagnosis. The explanation for
why the result in the meta-analysis that included studies that
reported the RR and raw data from cohort studies was not
significant could be based on the abovementioned information as
well as the low power due to a small sample size.
Exposure misclassification is a major problem when assessing
the roll of environmental factors in complex diseases. Most
individuals are not aware of the specific agents to which they have
been exposed, and databases do not provide further information.
None of the studies included in this meta-analysis employed an
objective method of exposure assessment. Only two studies
retrieved in this search [83,85] reported a direct-quantitative
measure of exposure (i.e. TCE in concentrations from 6 to over
500 parts-per-billion [83]). After performing the analyses accord-
ing to the exposure assessment category (figure S26) the final
common effect size remained significantly associated as risk factor.
A significant effort is necessary to determine the proper way to
test the causal factors for autoimmunity. Nevertheless, we believe
that identifying the causal pathways of toxics already known to be
associated with generating autoimmunity is a breakthrough.
Standardizing the pathways as validated biomarkers would lead
to more accurate studies. Future research on environmental
exposure will enhance our knowledge of the common mechanisms
associated with ADs.
In conclusion, an association between OSs exposure and ADs
was observed. This approach could be applied to any study of the
association between exposure to other toxics and ADs. Although
OSs exposure has not yet been sufficiently investigated, in order to
clarify their roles in ADs pathogenesis, there is a need to study
their relationship with genes associated, whether involved in
protection or susceptibility to each AD and their effects on
development of the autoimmune process.
Supporting Information
Figure S1 Forest plot of supplementary meta-analyses.
Footnote: final common effect size based on a random model.
Odds Ratio (95%CI) with raw data from case control and cohort
designed studies were included. Studies that provided uniquely RR
data were not included for statistical reasons. Each different
outcome of the studies with complex data structure was
included.GN: glomerulonephritis; MS: multiple sclerosis; PBC:
primary biliary cirrhosis; PSV: primary systemic vasculitis; RA:
rheumatoid arthritis; RP: Raynaud disease; SLE: systemic lupus
erythematosus; SSc: systemic sclerosis. The complex data structure
and non-cumulative results of articles showing multiple indepen-
dent or dependent subgroups included in the analysis was S1 Diot
E, et al.2 2002 Exposition to chlorinate.
(TIF)
Figure 4. Potential molecular mechanisms implicated in solvent autoimmune disease development. Footnote: Solid red arrows
represent known paths. Yellow dashed arrow represents hypothetical mechanisms (warranting future research), and red dashed line represents an
inhibited process. In susceptible individuals, activation paths are stronger (black arrows). See text for details. ROS: Reactive oxygen Species; NO: Nitric
Oxide.
doi:10.1371/journal.pone.0051506.g004
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Figure S2 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Diot E, et al.3 2002. Exposition to ketones.
(TIF)
Figure S3 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Diot E, et al.4 2002. Exposition to aromatic.
(TIF)
Figure S4 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Diot E, et al.5 2002. Exposition to toluene.
(TIF)
Figure S5 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Diot e, et al.6. Exposition to TCE.
(TIF)
Figure S6 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Nelson NA, et al 2. 1994 control population.
(TIF)
Figure S7 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Purdie GL, et al 2. 2011 including confirmed and
possible Raynaud.
(TIF)
Figure S8 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 10. Exposition to
Bicromade.
(TIF)
Figure S9 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 11. Exposition to Toluene.
(TIF)
Figure S10 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 12. Exposition to
Aromatic hydrocarbons.
(TIF)
Figure S11 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 13. Exposition to Aliphatic
hydrocarbons.
(TIF)
Figure S12 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 14. Exposition to
Fenfluramine.
(TIF)
Figure S13 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 15. Exposition to
Diethylpropion.
(TIF)
Figure S14 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 16. Exposition to L5
Ohtryptophan.
(TIF)
Figure S15 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 2. Exposition to Benzene.
(TIF)
Figure S16 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 3. Exposition to White
spirit.
(TIF)
Figure S17 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 4. Exposition to
Perchlorethylene.
(TIF)
Figure S18 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 5. Exposition to
Trichlorethylene.
(TIF)
Figure S19 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 6. Exposition to
Trichlorethane.
(TIF)
Figure S20 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 7. Exposition to vinyl
chloride.
(TIF)
Figure S21 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 8. Exposition to Urea
formaldehyde.
(TIF)
Figure S22 Forest plot of supplementary meta-analyses.
Final common effect size based on a random model. The studies
included and abbreviations are the same as in Figure S1 with the
exception of Thompson AE, et al. 2002 9. Exposition to Meta-
phenylenediamene.
(TIF)
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Figures S23 Sensitivity analysis. Footnote: Odds Ratio
(95%CI) excluding one study at a time. CI: confidence interval.
Diot, et al 1: organic solvent as a whole; Thompson AE, et al 1:
turpentine exposure (the most significant result); Purdie GL, et al
1: confirmed RP population; Nelson NA, et al 1. 1994: disabled
population.
(TIF)
Figures S24 Cumulative analysis. Footnote: Odds Ratio
(95%CI) The most relevant outcome per author was included. CI:
confidence interval. Diot, et al 1: organic solvent as a whole;
Thompson AE, et al 1: turpentine exposure (the most significant
result); Purdie GL, et al 1: confirmed RP population; Nelson NA,
et al 1. 1994: disabled population.
(TIF)
Figure S25 Forest plot of studies showing RR data and
raw data from cohort studies. Footnote: final common effect
size based on a random model. Risk Ratio (95%CI). CI:
confidence interval; AS: Ankylosing spondylitis; GN: glomerulo-
nephritis; MS: multiple sclerosis; RA: rheumatoid arthritis; RP:
Raynaud disease; SLE: systemic lupus erythematosus; SSc:
systemic sclerosis. Lundberg I, et al. 1 1994 painters AS; Lundberg
I, et al. 3 1994 Substantial RA men; Lundberg I, et al. 5 1994
substantial RA women; Purdie GL, et al 1: confirmed RP
population.
(TIF)
Figure S26 Forest plot of studies showing OR data
according to the exposure assessment category. Footnote:
Odds Ratio (95%CI). The most relevant outcome per author was
included. GN: glomerulonephritis; MS: multiple sclerosis; PBC:
primary biliary cirrhosis; PSV: primary systemic vasculitis; RA:
rheumatoid arthritis; RP: Raynaud disease; SLE: systemic lupus
erythematosus; SSc: systemic sclerosis. Diot, et al 1: organic
solvent as a whole; Thompson AE, et al 1: turpentine exposure
(the most significant result); Purdie GL, et al 1: confirmed RP
population; Nelson NA, et al 1. 1994: disabled population.
(TIF)
Figure S27 Funnel Plot of standard error by log odds
ratio. Footnote: X-axis: Log odds ratio. Y-axis: Standard Error.
(TIF)
Figure S28 Systematic Review Results for OSs molecu-
lar mechanisms related to responses of immune system
and ADs. Footnote: ADs: Autoimmune Diseases.
(TIF)
Text S1 PRISMA 2009 Checklist. PRISMA: Preferred
Reporting Items for Systematic Reviews and Meta-Analyses.
(DOCX)
Table S1 Studies not included in the Meta-analysis. Footnote:
AD: Autoimmune Disease; C-C: Case Control Study; OS:
Organic Solvent; SSc: Systemic Sclerosis or Scleroderma; SLE:
Systemic Lupus Erythematous; MS: Multiple Sclerosis; PSV:
Primary systemic vasculitis; RA: Rheumatoid Arthritis; PBC:
Primary Biliary Cirrhosis; GN: Glomerulonephritis; y/o: years old;
VC: vinyl chloride; TCE: trichloroethylene; PCE: Perchlorethy-
lene; RDX: Royal Demolition explosive; EEG: electroencephalo-
graphic study; PVC: polyvinyl chloride; ESRD: End Stage Renal
Disease.
(DOCX)
Table S2 Case reports and case series. Footnote: AD: Autoim-
mune Disease; OS: Organic Solvent; SSc: Systemic Sclerosis or
Scleroderma; SLE: Systemic Lupus Erythematous; MS: Multiple
Sclerosis; PSV: Primary systemic vasculitis; RA: Rheumatoid
Arthritis; RD: Raynaud Disease; PBC: Primary Biliary Cirrhosis;
GN: Glomerulonephritis; Anti- GBM: Anti-glomerular basement
membrane antibody; PM/DM: Polimiositis/Dermatomiositis; y/
o: years old; VC: vinyl chloride; TCE: trichloroethylene; PCE:
Perchlorethylene; Jo-1: anti-histidyl-t-RNA synthetase.
(DOCX)
Table S3 Search strategy related to solvent exposure and
immune alterations.
(DOCX)
Table S4 Effects of the exposition to organic solvents on
experimental models.
(DOCX)
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